{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-016920","form_type":"8-K","ticker":"USAQ","cik":"0000856984","company_name":"QHSLab, Inc.","filed_at":"2023-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.449276+00:00","generated_at":"2026-06-15T01:54:53.435638+00:00","sec_items":["7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"QHSLab Q1 2023 revenue $352,799, up 32% sequentially; gross margin 53.1%","bullets":["Net operating loss narrowed 17.1% to $120,758 from $145,701 in Q4 2022.","Digital Medicine ISP service revenue surged 324% sequentially to $34,467.","Allergy segment revenue increased 20% sequentially to $49,537.","Management expects Digital Medicine ISP revenue to grow ~100% in Q2 2023.","Gross margin target of +500 bps expansion for fiscal 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-016920","json":"https://secwatch.observer/filing/0001493152-23-016920.json","markdown":"https://secwatch.observer/filing/0001493152-23-016920.md","text":"https://secwatch.observer/filing/0001493152-23-016920.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/856984/000149315223016920/0001493152-23-016920-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/856984/000149315223016920/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T01:54:53.435638+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}